Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS

OBJECTIVE: Frequent administration of gadolinium-based contrast agents in multiple sclerosis (MS) may increase signal intensity (SI) unenhanced T1-weighted imaging MRI throughout the brain. We evaluated the association between lifetime cumulative doses of gadodiamide administration and increased SI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Zivadinov, Robert, Bergsland, Niels, Hagemeier, Jesper, Ramasamy, Deepa P., Dwyer, Michael G., Schweser, Ferdinand, Kolb, Channa, Weinstock-Guttman, Bianca, Hojnacki, David
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6709999/
https://ncbi.nlm.nih.gov/pubmed/31285398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000007892
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados